Product Information
TWIRLA 120-30 MCG/DAY PATCH is a brand product labeled by Agile Therapeutics, Inc., priced at $66.8047 per EA under NDC 71671010003. Its NADAC has been published 236 times since Dec 22, 2021.
Strength
2.3; 2.6 mg/1; mg/1
Manufacturer
Agile Therapeutics, Inc.NDC
71671010003
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; LEVONORGESTRELApproval Type
New Drug (NDA)
FDA Application
NDA204017On Market Since
9/11/2020
Pharmacological Classes
Price Statistics
The NADAC for TWIRLA 120-30 MCG/DAY PATCH has been published 236 times since Dec 22, 2021, and over the history we have for it it has risen 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $66.8047 per EA |
|---|---|
| All-time high | $67.2133 (May 13, 2026) |
| All-time low | $55.4013 (Dec 22, 2021) |
| 52-week high | $67.2133 |
| 52-week low | $65.2555 |
| Median price | $65.1883 |
| Average price | $63.2025 |
| Largest weekly change | +9.4% (Jul 20, 2022) |
| Weeks tracked | 236 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the levonorgestrel/ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TWIRLA 120-30 MCG/DAY PATCH?
The current National Average Drug Acquisition Cost (NADAC) for TWIRLA 120-30 MCG/DAY PATCH, manufactured by Agile Therapeutics, Inc., is $66.8047 per EA (NDC 71671010003), effective Jun 24, 2026.
How has the price of TWIRLA 120-30 MCG/DAY PATCH changed over time?
Over the history we have for it, the NADAC for TWIRLA 120-30 MCG/DAY PATCH has risen 20.6%. It has been tracked across 236 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for TWIRLA 120-30 MCG/DAY PATCH?
Since Dec 22, 2021, the NADAC for TWIRLA 120-30 MCG/DAY PATCH has ranged from a low of $55.4013 (Dec 22, 2021) to a high of $67.2133 (May 13, 2026), with a median of $65.1883 per EA.
Are there cheaper alternatives to TWIRLA 120-30 MCG/DAY PATCH?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TWIRLA 120-30 MCG/DAY PATCH, so no direct lower-cost alternative is listed.
Who manufactures TWIRLA 120-30 MCG/DAY PATCH?
TWIRLA 120-30 MCG/DAY PATCH (NDC 71671010003) is labeled by Agile Therapeutics, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification